Chizuko Hashimoto
Overview
Explore the profile of Chizuko Hashimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
771
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tachibana T, Izumi A, Arai S, Takeda T, Hirose N, Tamai Y, et al.
Exp Hematol
. 2025 Feb;
144:104746.
PMID: 39952596
The outcomes of patients with high-risk acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (HCT) remain poor despite many attempts at developing therapeutic strategies. Preconditioning interventions (PCIs) have...
2.
Ishii Y, Fujisawa S, Miyazaki T, Nakajima Y, Matsumura A, Fujimaki K, et al.
Int J Hematol
. 2024 Nov;
121(2):187-193.
PMID: 39560911
Although tyrosine kinase inhibitors (TKIs) have improved the prognosis of chronic myeloid leukemia (CML), some patients do not respond to TKIs. We evaluated 21 patients with CML treated with asciminib,...
3.
Arai S, Tachibana T, Izumi A, Takeda T, Tamai Y, Sato S, et al.
Int J Hematol
. 2024 May;
120(3):337-346.
PMID: 38795248
Measurable residual disease (MRD)-guided pre-emptive therapies are now widely used to prevent post-transplant hematological relapse in patients with acute myeloid leukemia (AML). This single-center retrospective study aimed to clarify the...
4.
Miyazaki T, Tachibana T, Suzuki T, Izumi A, Fujimaki K, Sato S, et al.
Transplant Cell Ther
. 2024 Jan;
30(4):400.e1-400.e9.
PMID: 38253183
There are no clear criteria for selecting elderly patients with hematologic malignancies eligible for allogeneic hematopoietic stem cell transplantation (HSCT). This study aimed to evaluate inflammatory and nutritional status biomarkers...
5.
Akimoto M, Miyazaki T, Takahashi H, Saigusa Y, Takeda T, Hibino Y, et al.
Int J Hematol
. 2024 Jan;
119(2):164-172.
PMID: 38233702
The efficacy of high-dose methotrexate (HD-MTX) for central nervous system (CNS) relapse prophylaxis in patients with high-risk diffuse large B-cell lymphoma (DLBCL) is controversial. We compared the prophylactic effects of...
6.
Takahashi H, Sakai R, Sakuma T, Matsumura A, Miyashita K, Ishii Y, et al.
Indian J Hematol Blood Transfus
. 2021 Mar;
37(1):60-66.
PMID: 33707836
We performed a retrospective analysis of DLBCL with breast involvement to compare the prognosis of primary breast lymphoma (PBL) to secondary breast lymphoma (SBL; especially in limited stage cases). We...
7.
Ando T, Fujisawa S, Teshigawara H, Ogusa E, Ishii Y, Miyashita K, et al.
Int J Hematol
. 2019 Apr;
109(6):673-683.
PMID: 30963469
We hypothesized that treatment-related weight loss is associated with worse outcomes following HSCT. Overall, 184 patients with AML who underwent induction therapy were classified according to d-BMI (BMI at transplant...
8.
Tachibana T, Andou T, Tanaka M, Ito S, Miyazaki T, Ishii Y, et al.
Clin Lymphoma Myeloma Leuk
. 2018 Apr;
18(6):415-421.
PMID: 29673622
Purpose: A multicenter retrospective analysis was performed to evaluate the clinical significance of serum ferritin at diagnosis in patients with acute myeloid leukemia (AML). Methods: The study cohort included 305...
9.
Tomita N, Yokoyama M, Yamamoto W, Watanabe R, Shimazu Y, Masaki Y, et al.
Leuk Lymphoma
. 2017 Jun;
59(1):97-104.
PMID: 28593796
Central nervous system (CNS) involvement is a serious complication in patients with diffuse large B-cell lymphoma (DLBCL) and evaluating CNS risk is an important issue. Using the standard international prognostic...
10.
Ando T, Yamazaki E, Ogusa E, Ishii Y, Yamamoto W, Motohashi K, et al.
Int J Hematol
. 2017 Jan;
105(5):623-630.
PMID: 28110409
Body mass index (BMI), which represents the proportion of weight to height, is a controversial prognostic factor for acute myeloid leukemia (AML). We evaluated prognostic value of BMI in Japanese...